http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17579852

Outgoing Links

Predicate Object
contentType Journal Article
issn 1471-2407
issueIdentifier 1
pageRange 747-
publicationName BMC Cancer
startingPage 747
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_332e414602a4f905c4c7f577007d1bb1
bibliographicCitation Lattanzio R, Iezzi M, Sala G, Tinari N, Falasca M, Alberti S, Buglioni S, Mottolese M, Perracchio L, Natali PG, Piantelli M. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes. BMC Cancer. 2019 Jul 30;19(1):747. PMID: 31362705; PMCID: PMC6668079.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5a97009b79aa5ec288a42ef0ea2b051
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_327ff6fca64c4e9fc8c32ae7639b3033
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4494-915X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5724ea931df8a961f9e78f4510a8605
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9803-4476
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_020e56c837858aa8083b26e69b934de0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d6413fabc43fe661dfca3cf06a1a4aa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_37034888c8292a375c652788c4d0f4c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b394089788fe8a7a07e838c1fb9be084
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd52eb25e9bcddaf56ca7b96c7a5eb53
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2771ab17a733adaddd4aec281b68d2ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14a78c933ea9a8bb67563e793e250d0d
date 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/s12885-019-5949-x
https://pubmed.ncbi.nlm.nih.gov/31362705
https://pubmed.ncbi.nlm.nih.gov/PMC6668079
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes
discusses http://id.nlm.nih.gov/mesh/M0225971
http://id.nlm.nih.gov/mesh/M000645694
http://id.nlm.nih.gov/mesh/M0495206
http://id.nlm.nih.gov/mesh/M0028859
http://id.nlm.nih.gov/mesh/M0018586
http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0018613
http://id.nlm.nih.gov/mesh/M0022149
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5335

Total number of triples: 43.